Alinity m HR HPV Assay: United States Clinical Trial Design and High-Risk Human Papillomavirus Prevalence
This analysis of primary screening participants in the Alinity m HR HPV assay US clinical trial demonstrates the benefits of including genotype-specific testing in cervical cancer screening programs.
Authors
- Danijela Lucic (ORCID: https://orcid.org/0000-0002-7276-489X)
- Richard L. Cullum
- Mark H. Stoler (ORCID: https://orcid.org/0000-0002-2784-1008)
- Thomas C. Wright (ORCID: https://orcid.org/0000-0001-7184-5199)
Institutions
- Abbott (United States) (US)
- University of Virginia (US)
- Columbia University (US)
Publication Details
- Journal
- Journal of Lower Genital Tract Disease
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1097/lgt.0000000000000900
- Citations
- 2
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 2.71